US Equity · NASDAQ · Earnings Dossier

VNDA earnings intelligence

Vanda Pharmaceuticals Inc

Healthcare · Biotechnology · USD reporting basis

Current earnings profile Mixed earnings transmission

Delivery and market response do not currently form a persistent directional pattern.

Evidence100/100 · Deep

Next scheduled catalyst

No forward date is currently stored

The historical dossier remains available while the next calendar date is unconfirmed.

0event risk

Inactive

Countdown-calendar proximity
EPS estimate-provider consensus
Estimate growth-versus comparable year-ago actual
Historical movement12.7%average absolute next weekly close

Three-year earnings transmission

Delivered earnings power versus market price

Three-year relationship unavailable

Earnings power must be positive through the latest visible week.

Beat rate58.3%7 beats in 12 measured quarters
Average surprise-12.1%median 16.1%
Delivery streak33 consecutive misses
Average response-7.8%12 measured reactions
Result-price confirmation50%same directional sign
Surprise variability89.3 ptspopulation dispersion

Estimate delivery

Actual EPS versus consensus

Actual and estimated EPS are displayed in reported currency on the same quarterly basis.

Price acceptance

Surprise and next weekly close

The response uses the first completed weekly close after the public report against the prior completed weekly close.

Fundamental delivery

Quarterly revenue and net income

Reported financial statements provide scale and earnings quality context around the headline EPS result.

Transmission matrix

Does price confirm delivery?

Upper right and lower left observations confirm the sign of delivery. The other quadrants expose expectation or resilience effects.

Current business context

Growth, quality and valuation

As of 9 Aug 2026
EPS growth-year on year
Revenue growth6.0%year on year
Average surprise-47.1%latest four quarters
SUE-0.30standardised surprise
Net margin-127.4%trailing basis
Cash conversion0.70xcash flow / net income
P/E-current snapshot
Data completeness79%alphavantage

Market context

Positioning into the event

Week ending 7 Aug 2026
Weekly close5.00 USDcompleted week
13-week return-20.4%price momentum
Fair-value gap-2.8%price versus current fair value
Relative strength-28.6exchange benchmark
Trend signalInactiveweekly architecture
Next-week statePositive55.1%

Market context describes the setup surrounding the report. It does not convert the earnings event into a directional forecast.

Reported evidence ledger

Quarter-by-quarter delivery and acceptance

Each row preserves the reported estimate, public date, statement context and conservative weekly reaction measurement.

12 quarters
Reported / periodEPS actual / estimateSurpriseEPS growthRevenue / growthNext close / four weeksRead
Reported / period30 Jul 202630 Jun 2026 · exact
EPS actual / estimate-1.04 / -0.51USD
Surprise-103.9%Miss
EPS growth-126.1%year on year
Revenue / growth50529000-3.9% · USD
Next close / four weeks-1.5% / -completed weekly closes
ReadConfirmedresult versus price sign
Reported / period6 May 202631 Mar 2026 · exact
EPS actual / estimate-0.82 / -0.69USD
Surprise-18.8%Miss
EPS growth-64.0%year on year
Revenue / growth51718000+3.4% · USD
Next close / four weeks-10.3% / -7.9%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period11 Feb 202631 Dec 2025 · exact
EPS actual / estimate-2.39 / -1.32USD
Surprise-81.1%Miss
EPS growth-2887.5%year on year
Revenue / growth57216000+7.6% · USD
Next close / four weeks-19.6% / +4.2%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period29 Oct 202530 Sep 2025 · exact
EPS actual / estimate-0.38 / -0.45USD
Surprise+15.6%Beat
EPS growth-322.2%year on year
Revenue / growth56258000+18.1% · USD
Next close / four weeks-20.9% / -12.7%completed weekly closes
ReadDivergedresult versus price sign
Reported / period31 Jul 202530 Jun 2025 · exact
EPS actual / estimate-0.46 / -0.36USD
Surprise-27.8%Miss
EPS growth-475.0%year on year
Revenue / growth52590000+4.2% · USD
Next close / four weeks-11.6% / +0.2%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period7 May 202531 Mar 2025 · exact
EPS actual / estimate-0.50 / -0.60USD
Surprise+16.7%Beat
EPS growth-614.3%year on year
Revenue / growth50041000+5.4% · USD
Next close / four weeks-13.6% / -5.0%completed weekly closes
ReadDivergedresult versus price sign
Reported / period13 Feb 202531 Dec 2024 · exact
EPS actual / estimate-0.08 / -0.11USD
Surprise+27.3%Beat
EPS growth-100.0%year on year
Revenue / growth53185000+17.5% · USD
Next close / four weeks-7.9% / +1.0%completed weekly closes
ReadDivergedresult versus price sign
Reported / period6 Nov 202430 Sep 2024 · exact
EPS actual / estimate-0.09 / -0.16USD
Surprise+43.8%Beat
EPS growth-3850.0%year on year
Revenue / growth47651000+22.8% · USD
Next close / four weeks+11.4% / +10.5%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period31 Jul 202430 Jun 2024 · exact
EPS actual / estimate-0.08 / -0.21USD
Surprise+61.9%Beat
EPS growth-year on year
Revenue / growth50474000- · USD
Next close / four weeks-12.6% / -11.7%completed weekly closes
ReadDivergedresult versus price sign
Reported / period8 May 202431 Mar 2024 · exact
EPS actual / estimate-0.07 / 0.05USD
Surprise-240.0%Miss
EPS growth-year on year
Revenue / growth47462000- · USD
Next close / four weeks+3.3% / +4.7%completed weekly closes
ReadDivergedresult versus price sign
Reported / period7 Feb 202431 Dec 2023 · exact
EPS actual / estimate-0.04 / -0.09USD
Surprise+55.6%Beat
EPS growth-year on year
Revenue / growth45271000- · USD
Next close / four weeks+14.6% / +27.0%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period8 Nov 202330 Sep 2023 · exact
EPS actual / estimate0.00 / -0.04USD
Surprise+106.0%Beat
EPS growth-year on year
Revenue / growth38815000- · USD
Next close / four weeks-24.6% / -13.7%completed weekly closes
ReadDivergedresult versus price sign

Reproducible method

How the earnings dossier is measured

Descriptive, not predictive
Estimate delivery

Reported diluted EPS is compared with the stored estimate for the same fiscal period. Moves within ±0.5% are classified as in-line.

Price response

The first completed weekly close after the public date is compared with the prior completed weekly close. Four-week response uses the first close at least 21 days later.

Event risk

Risk combines proximity, average absolute price movement, surprise variability, estimate availability and timing certainty. It does not score direction.

Data discipline

Exact public dates are used when stored. Missing estimates, timing and statement fields remain missing. No result or reaction is filled from a future observation.

Independent market research for education. Not investment advice, a recommendation, forecast, target or execution instruction.

Evidence context